April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Major LOXL1 Risk Allele is Reversed in a South African XFG Population
Author Affiliations & Notes
  • S. E. Williams
    St John Eye Hospital,
    University of the Witwatersrand, Johannesburg, South Africa
  • B. T. Whigham
    Medicine and Ophthalmology, Duke University, Durham, North Carolina
  • Y. Liu
    Medicine and Ophthalmology, Duke University, Durham, North Carolina
  • M. Ramsay
    University of the Witwatersrand, Johannesburg, South Africa
  • T. R. Carmichael
    University of the Witwatersrand, Johannesburg, South Africa
  • X. Qin
    Medicine and Ophthalmology, Duke University, Durham, North Carolina
  • S. Schmidt
    Medicine and Ophthalmology, Duke University, Durham, North Carolina
  • M. A. Hauser
    Medicine and Ophthalmology, Duke University, Durham, North Carolina
  • R. R. Allingham
    Medicine and Ophthalmology, Duke University, Durham, North Carolina
  • Footnotes
    Commercial Relationships  S.E. Williams, None; B.T. Whigham, None; Y. Liu, None; M. Ramsay, None; T.R. Carmichael, None; X. Qin, None; S. Schmidt, None; M.A. Hauser, None; R.R. Allingham, None.
  • Footnotes
    Support  We thank all the study participants and the study staff. This work is supported by NIH grants R01EY013315 (MAH) R01EY019126 (MAH) R01EY015543 (RRA) R03EY014939 (RRA)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2156. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. E. Williams, B. T. Whigham, Y. Liu, M. Ramsay, T. R. Carmichael, X. Qin, S. Schmidt, M. A. Hauser, R. R. Allingham; Major LOXL1 Risk Allele is Reversed in a South African XFG Population. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2156.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate whether variants in the lysyl oxidase-like 1 (LOXL1) gene are associated with pseudoexfoliation glaucoma (XFG) and primary open-angle glaucoma (POAG) in an African population from South Africa.

Methods: : Individuals with XFG or POAG were identified using standard clinical examination techniques. Fifty individuals were collected for each of the three groups: XFG, POAG, and normal controls. The complete coding region of the LOXL1 gene was sequenced using PCR-based Sanger method with an ABI 3730 capillary sequencer (Applied BioSystems). The allele frequencies of the identified sequence variants were compared between XFG or POAG and controls using Fisher’s exact test or Chi-square test.

Results: : We identified several coding variants in the LOXL1 gene, including rs3825942 and rs1048661. The allele frequencies of both rs3825942 and rs1048661 differed significantly between the XFG and control subjects from South Africa (p= 6.7x10-12 and 1.6x10-4 respectively, two-tailed Fisher’s Exact Probability Test). As in other populations, G is the risk allele for rs1048661 (encoding arginine); however, the A allele of rs3825942 (encoding aspartic acid) is associated with risk in this South African population, in sharp contrast to the G allele (encoding glycine) reported in multiple other populations. There was no significant difference in the allele frequencies of coding variants in the LOXL1 gene between POAG and control subjects.

Conclusions: : This represents the first genetic association study of LOXL1 in an African population with XFG. We have confirmed the association between variants of LOXL1 and XFG. To date, the G allele of the major susceptibility variant rs3825942 has consistently been shown in multiple populations to increase the risk of XFG. Surprisingly, we have found a strong association with the opposite allele in the South African population. This suggests that other as yet unknown variants of LOXL1 contribute to the genetic risk of XFG.

Keywords: candidate gene analysis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×